Medtronic Price to Free Cash Flow Ratio 2012-2026 | MDT
Historical price to free cash flow ratio values for Medtronic (MDT) since 2012.
| Medtronic Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-16 | 81.32 | 20.15 | |
| 2025-10-31 | 89.31 | $4.04 | 22.13 |
| 2025-07-31 | 88.19 | $4.11 | 21.44 |
| 2025-04-30 | 82.15 | $4.02 | 20.44 |
| 2025-01-31 | 87.33 | $4.19 | 20.83 |
| 2024-10-31 | 85.08 | $4.16 | 20.45 |
| 2024-07-31 | 75.97 | $3.88 | 19.59 |
| 2024-04-30 | 75.23 | $3.91 | 19.24 |
| 2024-01-31 | 81.40 | $3.70 | 22.00 |
| 2023-10-31 | 65.06 | $3.03 | 21.44 |
| 2023-07-31 | 80.24 | $3.33 | 24.06 |
| 2023-04-30 | 82.50 | $3.44 | 24.01 |
| 2023-01-31 | 75.27 | $3.11 | 24.23 |
| 2022-10-31 | 77.86 | $3.59 | 21.71 |
| 2022-07-31 | 81.83 | $4.24 | 19.29 |
| 2022-04-30 | 91.60 | $4.42 | 20.71 |
| 2022-01-31 | 90.29 | $4.21 | 21.47 |
| 2021-10-31 | 103.91 | $4.26 | 24.39 |
| 2021-07-31 | 113.28 | $4.32 | 26.20 |
| 2021-04-30 | 112.38 | $3.61 | 31.15 |
| 2021-01-31 | 95.09 | $3.42 | 27.81 |
| 2020-10-31 | 85.47 | $3.52 | 24.30 |
| 2020-07-31 | 81.53 | $3.52 | 23.16 |
| 2020-04-30 | 81.97 | $4.46 | 18.39 |
| 2020-01-31 | 96.32 | $4.91 | 19.61 |
| 2019-10-31 | 90.43 | $4.65 | 19.43 |
| 2019-07-31 | 84.22 | $4.19 | 20.11 |
| 2019-04-30 | 72.97 | $4.33 | 16.87 |
| 2019-01-31 | 72.23 | $3.57 | 20.23 |
| 2018-10-31 | 72.99 | $3.56 | 20.49 |
| 2018-07-31 | 72.95 | $3.34 | 21.82 |
| 2018-04-30 | 64.41 | $2.64 | 24.37 |
| 2018-01-31 | 68.64 | $3.14 | 21.87 |
| 2017-10-31 | 63.99 | $3.12 | 20.49 |
| 2017-07-31 | 66.34 | $3.51 | 18.90 |
| 2017-04-30 | 65.30 | $4.04 | 16.15 |
| 2017-01-31 | 59.43 | $3.70 | 16.06 |
| 2016-10-31 | 63.74 | $3.51 | 18.15 |
| 2016-07-31 | 67.76 | $3.38 | 20.04 |
| 2016-04-30 | 60.90 | $2.93 | 20.81 |
| 2016-01-31 | 58.12 | $3.47 | 16.75 |
| 2015-10-31 | 56.31 | $4.04 | 13.94 |
| 2015-07-31 | 59.39 | $4.12 | 14.42 |
| 2015-04-30 | 56.12 | $3.91 | 14.37 |
| 2015-01-31 | 53.61 | $3.88 | 13.82 |
| 2014-10-31 | 50.96 | $3.72 | 13.72 |
| 2014-07-31 | 45.94 | $3.82 | 12.04 |
| 2014-04-30 | 43.55 | $4.50 | 9.67 |
| 2014-01-31 | 41.69 | $4.40 | 9.47 |
| 2013-10-31 | 42.10 | $4.21 | 10.00 |
| 2013-07-31 | 40.31 | $4.07 | 9.91 |
| 2013-04-30 | 33.88 | $4.37 | 7.76 |
| 2013-01-31 | 33.63 | $4.15 | 8.11 |
| 2012-10-31 | 29.83 | $3.82 | 7.80 |
| 2012-07-31 | 28.11 | $4.02 | 6.98 |
| 2012-04-30 | 27.06 | $3.76 | 7.20 |
| 2012-01-31 | 27.15 | $3.50 | 7.77 |
| 2011-10-31 | 24.30 | $3.56 | 6.83 |
| 2011-07-31 | 25.03 | $3.28 | 7.64 |
| 2011-04-30 | 28.80 | $3.00 | 9.62 |
| 2011-01-31 | 26.28 | $3.34 | 7.88 |
| 2010-10-31 | 24.02 | $3.52 | 6.81 |
| 2010-07-31 | 25.04 | $3.42 | 7.31 |
| 2010-04-30 | 29.40 | $3.21 | 9.17 |
| 2010-01-31 | 28.73 | $3.13 | 9.18 |
| 2009-10-31 | 23.81 | $2.82 | 8.45 |
| 2009-07-31 | 23.49 | $2.83 | 8.30 |
| 2009-04-30 | 21.09 | $3.00 | 7.03 |
| 2009-01-31 | 21.93 | $2.54 | 8.64 |
| 2008-10-31 | 26.25 | $2.47 | 10.61 |
| 2008-07-31 | 34.25 | $2.52 | 13.58 |
| 2008-04-30 | 31.45 | $2.60 | 12.09 |
| 2008-01-31 | 29.96 | $2.82 | 10.63 |
| 2007-10-31 | 30.49 | $2.49 | 12.25 |
| 2007-07-31 | 32.49 | $2.35 | 13.84 |
| 2007-04-30 | 33.86 | $2.07 | 16.35 |
| 2007-01-31 | 34.12 | $1.94 | 17.60 |
| 2006-10-31 | 31.01 | $2.40 | 12.92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $111.968B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |